[PDF] Olumiant (baricitinib) patient alert card

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
11 December 2017

Abstract

This alert card has been produced by manufacturers for patients to keep to highlight to healthcare professionals that they are on this treatment. It highlights that it should not be used during pregnancy, and that infections are a known adverse effect of treatment.